skip to Main Content


Accelerating breast cancer immunotherapy by
harnessing tumor associated macrophages.

The Guerriero Lab aims to design clinically effective strategies to promote T-cell activation and weaken the immune-suppressive tumor microenvironment to improve immunotherapy response rates in breast cancer patients. We seek to identify tumor-promoting tumor macrophages in breast tumors before and after therapy, elucidate their molecular and metabolic regulation that promotes immune suppression and therapy-resistance and determine how tumor macrophage phenotype, metabolism and function can be modulated for anti-tumor responses.

02Feb 23

Lab Hockey Outing

The lab had a great time at the Northeastern hockey game with friends and family. A great win by the Huskies! #GoHuskies

read more
01Dec 22

Ludwig Retreat 2022

On November 21st the Guerriero lab attended the 2022 Ludwig Retreat. It was amazing to connect with everyone and discuss all the great work being done at the Ludwig Center…

read more
01Dec 22

SITC 2022

The lab had a great time at SITC 2022 here in Boston. After great talks at the conference, a chance to discuss with some great food.

read more
Back To Top